# Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

> **NCT01220232** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Abacavir/Lamivudine
- **DRUG:** Abacavir/Lamivudine
- **DRUG:** Lersivirine

## Key facts

- **NCT ID:** NCT01220232
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220232, "Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01220232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*